Back to VANGUARD GROUP INC VANGUARD GROUP INC

ARWRARWR
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in ARROWHEAD PHARMACEUTICALS IN

VANGUARD GROUP INC holds 15.3M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $1B as of 2025-Q4. The position was decreased (-4.6% shares). ARWR represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$1B

Current Shares

15.3M

Total Value Change

+$778.4M

Total Shares Change

+3.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Decreased
15.3M
-4.6%
$1B0.0%$67.25
0
2025-Q3
Increased
16M
+3.3%
$553.1M0.0%$33.78
32
2025-Q2
Increased
15.5M
+17.6%
$245.3M0.0%$16.08
36
2025-Q1
Increased
13.2M
+8.4%
$168.2M0.0%$13.82
33
2024-Q4
Decreased
12.2M
-0.4%
$229.1M0.0%$18.61
0
2024-Q3
New
12.2M
-
$236.9M0.0%$19.67
42

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used